Welcome to our dedicated page for Senestech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on Senestech stock.
SenesTech, Inc. develops and commercializes fertility-control products for managing animal pest populations, with current products focused on rat and mouse populations. Its product names include ContraPest, Evolve Rat, and Evolve Mouse, which are used within pest-management programs as alternatives or complements to traditional rodent-control methods.
Company news centers on Evolve commercialization, e-commerce and direct-to-consumer sales channels, Amazon marketplace management, field-study data on rodent activity, product approvals in international markets, quarterly and annual financial results, capital runway commentary, and executive leadership or board governance updates.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
SenesTech, Inc. (NASDAQ: SNES) recently showcased its rodent fertility control product, ContraPest®, at PEAK 2023, the largest poultry industry trade show in the U.S. The event, held in Minneapolis, featured over 250 exhibitors and attracted approximately 2,000 visitors. CEO Joel Fruendt emphasized the economic benefits of ContraPest, highlighting a successful deployment that saved a customer over $600,000 with a modest investment of $5,000. The poultry market presents a significant opportunity for SenesTech, with an addressable size nearing $200 million. The company demonstrated a 95% reduction in rat populations through its product, further solidifying its position in integrated pest management. SenesTech's innovative approach aims to humanely manage animal populations and improve environmental health.